Market cap
$5,521 Mln
Revenue (TTM)
$268 Mln
P/E Ratio
2399
P/B Ratio
6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$3 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
85.2
-
Debt to Equity
0.3
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
230,151,008
10 Years Aggregate
CFO
£555.21 Mln
EBITDA
£603.32 Mln
Net Profit
£281.42 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Abcam PLC (ABCM)
| 54.2 | 3.3 | 5.5 | 50.9 | 7.0 | -- | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2022
|
2021
|
|---|---|---|
|
Abcam PLC (ABCM)
| -33.9 | 9.3 |
|
S&P Small-Cap 600
| -17.4 | 25.3 |
|
BSE Sensex
| 4.4 | 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Abcam PLC (ABCM)
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated... antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. As of December 6, 2023, Abcam plc operates as a subsidiary of Danaher Corporation. Read more
-
CEO & Exec. Director
Mr. Alan Thomas Hirzel BS, M.B.A., M.S., MBA, MS
-
CEO & Exec. Director
Mr. Alan Thomas Hirzel BS, M.B.A., M.S., MBA, MS
-
Headquarters
Cambridge
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Abcam PLC (ABCM)
What is the current share price of Abcam PLC (ABCM) Today?
The share price of Abcam PLC (ABCM) is $23.99 (NASDAQ) as of 15-Dec-2023 09:30 EDT. Abcam PLC (ABCM) has given a return of 7.02% in the last 3 years.
What is the current PB & PE ratio of Abcam PLC (ABCM)?
Since, TTM earnings of Abcam PLC (ABCM) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2023 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-- |
-- |
2020 |
-- |
-- |
2019 |
-- |
-- |
What is the 52 Week High and Low of Abcam PLC (ABCM)?
The 52-week high and low of Abcam PLC (ABCM) are Rs -- and Rs -- as of 29-Aug-2026.
What is the market cap of Abcam PLC (ABCM)?
Abcam PLC (ABCM) has a market capitalisation of $ 5,521 Mln as on 18-Dec-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in Abcam PLC (ABCM)?
Before investing in Abcam PLC (ABCM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.